Bicara Therapeutics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BCAX | CBIO | AVBP | CGEM | IMTX | IDYA | |
|---|---|---|---|---|---|---|
| Market cap | 1.15B | 537.14M | 811.61M | 918.80M | 1.10B | 3.48B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -4.9 | -5.5 | -4.2 | -5.9 | -3.5 | -9.0 |
| Price/book | 2.4 | 3.0 | 2.2 | 3.0 | 2.2 | 2.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +0.12% | +45.46% | −17.70% | +98.34% | −26.36% | +34.89% |
| Today | −0.97% | −3.02% | −1.61% | −3.73% | −2.96% | −0.14% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BCAX news ›Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock Rated “Moderate Buy” by Sell-Side Brokerages
View Our Latest Research Report on BCAX Shares of NASDAQ:BCAX opened at $16.56 on Wednesday. Bicara Therapeutics has a 12 month low of $13.70 and a 12 month high of $30.99. The company has a 50-day moving average price of $23.16 and a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
defenseworld.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.